piribedil and Tremor
piribedil has been researched along with Tremor in 11 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "The authors present ten cases of essential tremor, studied before and after administration of clonidine with clinical tests and electrophysiological recordings." | 7.67 | Clonidine in essential tremor: preliminary observations from an open trial. ( Caccia, MR; Mangoni, A, 1985) |
| "Several controlled trials have shown that the dopamine agonist, Trivastal (piribedil), is active in the treatment of Parkinson's disease, particularly with regard to tremor." | 5.07 | Activity and acceptability of piribedil in Parkinson's disease: a multicentre study. ( Rondot, P; Ziegler, M, 1992) |
| "Electromyographic (EMG) activity of abnormal involuntary movements and their modifications after Piribedil, a dopaminergic agonist, were analysed in patients presenting with tremor or tardive dyskinesia induced by treatment with neuroleptics." | 3.67 | EMG patterns in abnormal involuntary movements induced by neuroleptics. ( Bathien, N; Koutlidis, RM; Rondot, P, 1984) |
| "The authors present ten cases of essential tremor, studied before and after administration of clonidine with clinical tests and electrophysiological recordings." | 3.67 | Clonidine in essential tremor: preliminary observations from an open trial. ( Caccia, MR; Mangoni, A, 1985) |
| "Sixty patients with different types of Parkinson's disease (PD), the disease stage 2." | 2.71 | [An impact of pronoran on cognitive and affective disorders in Parkinson's disease]. ( Golubev, VL; Pilipovich, AA, 2005) |
Research
Studies (11)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (81.82) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Pilipovich, AA | 1 |
| Golubev, VL | 1 |
| Bathien, N | 2 |
| Koutlidis, RM | 1 |
| Rondot, P | 3 |
| Hungerbühler, JP | 1 |
| Regli, F | 1 |
| Lieberman, AN | 1 |
| Shopsin, B | 1 |
| Brun, YL | 1 |
| Boal, D | 1 |
| Zolfaghari, M | 1 |
| Engel, J | 1 |
| Granerus, AK | 1 |
| Svanborg, A | 1 |
| Ohmoto, T | 1 |
| Miyamoto, T | 1 |
| Baba, Y | 1 |
| Dumas, JL | 1 |
| Emile, J | 2 |
| Chanelet, J | 2 |
| Truelle, JL | 2 |
| Bastard, J | 2 |
| Ziegler, M | 1 |
| Caccia, MR | 1 |
| Mangoni, A | 1 |
Reviews
1 review available for piribedil and Tremor
| Article | Year |
|---|---|
[Considerations in the drug treatment of parkinsonism (author's transl)].
Topics: Amantadine; Apomorphine; Bromocriptine; Dopamine; Ergolines; Extrapyramidal Tracts; Female; Humans; | 1978 |
Trials
6 trials available for piribedil and Tremor
| Article | Year |
|---|---|
[An impact of pronoran on cognitive and affective disorders in Parkinson's disease].
Topics: Adult; Affect; Aged; Antiparkinson Agents; Cognition; Cognition Disorders; Female; Humans; Male; Mid | 2005 |
Studies on piribedil in Parkinsonism.
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Humans; Huntington Disease; Mental Disorders | 1975 |
Indications of piribedil in L-DOPA-treated parkinsonian patients: physiopathologic implications.
Topics: Adult; Aged; Benserazide; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Levodopa; Male; | 1975 |
Action of piribedil in Parkinson's disease: I.V. test and oral treatment.
Topics: Administration, Oral; Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Inject | 1975 |
[Polygraphic recording of tremor and of hypertonic phenomena. Application to the action of various drugs].
Topics: Antiparkinson Agents; Apomorphine; Clinical Trials as Topic; Dopa Decarboxylase; Drug Combinations; | 1975 |
Activity and acceptability of piribedil in Parkinson's disease: a multicentre study.
Topics: Adult; Aged; Depression; Female; Humans; Male; Middle Aged; Parkinson Disease; Piribedil; Treatment | 1992 |
Other Studies
4 other studies available for piribedil and Tremor
| Article | Year |
|---|---|
EMG patterns in abnormal involuntary movements induced by neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Electromyography; Female; Humans; Male; | 1984 |
Piribedil in Parkinson's syndrome: a clinical study.
Topics: Activities of Daily Living; Aged; Alkaline Phosphatase; Brain Diseases; Dose-Response Relationship, | 1975 |
[Experimental and clinical study on the dopaminergic receptor stimulating agents (author's transl)].
Topics: Adult; Aged; Animals; Bromocriptine; Dopamine; Female; Haplorhini; Humans; Male; Middle Aged; Parkin | 1977 |
Clonidine in essential tremor: preliminary observations from an open trial.
Topics: Aged; Clonidine; Diazepam; Female; Handwriting; Humans; Levodopa; Male; Middle Aged; Piribedil; Trem | 1985 |